Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
83.82
-0.55 (-0.65%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,913,374
Open
83.52
Bid (Size)
87.00 (200)
Ask (Size)
88.45 (1,200)
Prev. Close
84.37
Today's Range
82.99 - 84.45
52wk Range
72.30 - 96.29
Shares Outstanding
580,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Edwards Lifesciences Q2 Earnings Call Highlights
↗
Today 19:06 EDT
Edwards Lifesciences (NYSE:EW) reported stronger-than-expected second-quarter 2026 results, with management pointing to broad growth across transcatheter aortic valve replacement, transcatheter mitral...
Via
MarketBeat
Topics
Earnings
Which S&P500 stocks are moving after the closing bell on Thursday?
↗
Today 17:05 EDT
Via
Chartmill
Performance
YTD
-1.8%
-1.8%
1 Month
-2.4%
-2.4%
3 Month
+2.8%
+2.8%
6 Month
-1.6%
-1.6%
1 Year
+9.9%
+9.9%
More News
Read More
Edwards Lifesciences (NYSE:EW) Raises Guidance After Solid Q2 Earnings, Stock Surges 6%
↗
Today 16:50 EDT
Via
Chartmill
Edwards Lifesciences Reports Second Quarter Results
Today 16:15 EDT
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
July 16, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
June 16, 2026
Via
Chartmill
Edwards Lifesciences Corp (NYSE:EW) Shares Surge After Q1 Earnings Beat and Raised Guidance
↗
April 23, 2026
Via
Chartmill
Topics
Earnings
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
June 26, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
What's going on in today's pre-market session: S&P500 movers
↗
June 22, 2026
Via
Chartmill
Exploring the top movers within the S&P500 index during today's session.
↗
June 16, 2026
Via
Chartmill
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
May 02, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
April 28, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Top gainers and losers in the S&P500 index during Thursday's after-hours session.
↗
April 23, 2026
Via
Chartmill
Edwards Lifesciences Reports First Quarter Results
April 23, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
From
USA News Group
Via
GlobeNewswire
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
April 16, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
April 15, 2026
Via
Chartmill
Topics
Lawsuit
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
April 01, 2026
Via
Finterra
Topics
Economy
Lawsuit
Product Recall
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
March 30, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
↗
March 15, 2026
Via
The Motley Fool
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
↗
March 15, 2026
Via
The Motley Fool
Friday's session: top gainers and losers in the S&P500 index
↗
March 13, 2026
Via
Chartmill
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
February 26, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing
↗
February 20, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
February 19, 2026
Via
MarketMinute
Frequently Asked Questions
Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded.
What exchange does Edwards Lifesciences trade on?
Edwards Lifesciences trades on the New York Stock Exchange
What is the ticker symbol for Edwards Lifesciences?
The ticker symbol for Edwards Lifesciences is EW on the New York Stock Exchange
What is the current price of Edwards Lifesciences?
The current price of Edwards Lifesciences is 83.82
When was Edwards Lifesciences last traded?
The last trade of Edwards Lifesciences was at 07/23/26 07:00 PM ET
What is the market capitalization of Edwards Lifesciences?
The market capitalization of Edwards Lifesciences is 48.68B
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 49B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.